William Hudson

10PUBLICATIONS
86CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 10, 2026
Single-cell TCR mapping reveals spatially coordinated T cell states in head and neck cancer.

Kelli A McCord, Emerald Kan, Sean Hyslop

|Oct 06, 2025
Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting.

Pedram Yadollahi, Kelli A McCord, Yang Li

|Jul 31, 2025
Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.

Rutulkumar Patel, Kalil Saab, Lixia Luo

|Apr 10, 2025
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma.

Hee-Jin Jang, Meera Patel, Daniel Y Wang

|Feb 12, 2025
MAGE-A4 induces non-small cell lung cancer and tumor-promoting plasma cell accumulation.

Dominique Armstrong, Cheng-Yen Chang, Monica J Hong

|Aug 25, 2023
PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors.

Amanda L Gill, Peter H Wang, Judong Lee

Pageof 2

Frequent Collaborators

5 joint publications

Rafi Ahmed

4 joint publications

Andreas Wieland

3 joint publications

Vlad C Sandulache

3 joint publications

Haydn T Kissick